Triamcinolone Withdrawn Phase 2 Trials for Uveitis / Macular Edema Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00846625Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids